Global Therapeutic Nuclear Medicines Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Therapeutic Nuclear Medicines market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Therapeutic Nuclear Medicines market are covered in Chapter 9:
Acrotech Biopharma.
Progenics Pharmaceuticals
Curium Pharmaceuticals
Q BioMed
Lantheus
Jubilant DraxImage
International Isotopes
Dongcheng
Novartis AG
China Isotope and Radiation
Bayer
In Chapter 5 and Chapter 7.3, based on types, the Therapeutic Nuclear Medicines market from 2017 to 2027 is primarily split into:
Radium-223
Lutetium-177
Iodine-131
Other
In Chapter 6 and Chapter 7.4, based on applications, the Therapeutic Nuclear Medicines market from 2017 to 2027 covers:
Thyroid
Bone Metastasis
Lymphoma
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Therapeutic Nuclear Medicines market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Therapeutic Nuclear Medicines Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Therapeutic Nuclear Medicines market are covered in Chapter 9:
Acrotech Biopharma.
Progenics Pharmaceuticals
Curium Pharmaceuticals
Q BioMed
Lantheus
Jubilant DraxImage
International Isotopes
Dongcheng
Novartis AG
China Isotope and Radiation
Bayer
In Chapter 5 and Chapter 7.3, based on types, the Therapeutic Nuclear Medicines market from 2017 to 2027 is primarily split into:
Radium-223
Lutetium-177
Iodine-131
Other
In Chapter 6 and Chapter 7.4, based on applications, the Therapeutic Nuclear Medicines market from 2017 to 2027 covers:
Thyroid
Bone Metastasis
Lymphoma
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Therapeutic Nuclear Medicines market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Therapeutic Nuclear Medicines Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 THERAPEUTIC NUCLEAR MEDICINES MARKET OVERVIEW
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines Market
1.2 Therapeutic Nuclear Medicines Market Segment by Type
1.2.1 Global Therapeutic Nuclear Medicines Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Therapeutic Nuclear Medicines Market Segment by Application
1.3.1 Therapeutic Nuclear Medicines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Therapeutic Nuclear Medicines Market, Region Wise (2017-2027)
1.4.1 Global Therapeutic Nuclear Medicines Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.3 Europe Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.4 China Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.5 Japan Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.6 India Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.8 Latin America Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.5 Global Market Size of Therapeutic Nuclear Medicines (2017-2027)
1.5.1 Global Therapeutic Nuclear Medicines Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Therapeutic Nuclear Medicines Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Therapeutic Nuclear Medicines Market
2 INDUSTRY OUTLOOK
2.1 Therapeutic Nuclear Medicines Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Therapeutic Nuclear Medicines Market Drivers Analysis
2.4 Therapeutic Nuclear Medicines Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Therapeutic Nuclear Medicines Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Therapeutic Nuclear Medicines Industry Development
3 GLOBAL THERAPEUTIC NUCLEAR MEDICINES MARKET LANDSCAPE BY PLAYER
3.1 Global Therapeutic Nuclear Medicines Sales Volume and Share by Player (2017-2022)
3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Player (2017-2022)
3.3 Global Therapeutic Nuclear Medicines Average Price by Player (2017-2022)
3.4 Global Therapeutic Nuclear Medicines Gross Margin by Player (2017-2022)
3.5 Therapeutic Nuclear Medicines Market Competitive Situation and Trends
3.5.1 Therapeutic Nuclear Medicines Market Concentration Rate
3.5.2 Therapeutic Nuclear Medicines Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL THERAPEUTIC NUCLEAR MEDICINES SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Therapeutic Nuclear Medicines Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Therapeutic Nuclear Medicines Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Therapeutic Nuclear Medicines Market Under COVID-19
4.5 Europe Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Therapeutic Nuclear Medicines Market Under COVID-19
4.6 China Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Therapeutic Nuclear Medicines Market Under COVID-19
4.7 Japan Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Therapeutic Nuclear Medicines Market Under COVID-19
4.8 India Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Therapeutic Nuclear Medicines Market Under COVID-19
4.9 Southeast Asia Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Therapeutic Nuclear Medicines Market Under COVID-19
4.10 Latin America Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Therapeutic Nuclear Medicines Market Under COVID-19
4.11 Middle East and Africa Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Therapeutic Nuclear Medicines Market Under COVID-19
5 GLOBAL THERAPEUTIC NUCLEAR MEDICINES SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Therapeutic Nuclear Medicines Sales Volume and Market Share by Type (2017-2022)
5.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2017-2022)
5.3 Global Therapeutic Nuclear Medicines Price by Type (2017-2022)
5.4 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate of Radium-223 (2017-2022)
5.4.2 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate of Lutetium-177 (2017-2022)
5.4.3 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate of Iodine-131 (2017-2022)
5.4.4 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate of Other (2017-2022)
6 GLOBAL THERAPEUTIC NUCLEAR MEDICINES MARKET ANALYSIS BY APPLICATION
6.1 Global Therapeutic Nuclear Medicines Consumption and Market Share by Application (2017-2022)
6.2 Global Therapeutic Nuclear Medicines Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Therapeutic Nuclear Medicines Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Thyroid (2017-2022)
6.3.2 Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Bone Metastasis (2017-2022)
6.3.3 Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Lymphoma (2017-2022)
6.3.4 Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Other (2017-2022)
7 GLOBAL THERAPEUTIC NUCLEAR MEDICINES MARKET FORECAST (2022-2027)
7.1 Global Therapeutic Nuclear Medicines Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Therapeutic Nuclear Medicines Price and Trend Forecast (2022-2027)
7.2 Global Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Therapeutic Nuclear Medicines Revenue and Growth Rate of Radium-223 (2022-2027)
7.3.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate of Lutetium-177 (2022-2027)
7.3.3 Global Therapeutic Nuclear Medicines Revenue and Growth Rate of Iodine-131 (2022-2027)
7.3.4 Global Therapeutic Nuclear Medicines Revenue and Growth Rate of Other (2022-2027)
7.4 Global Therapeutic Nuclear Medicines Consumption Forecast by Application (2022-2027)
7.4.1 Global Therapeutic Nuclear Medicines Consumption Value and Growth Rate of Thyroid(2022-2027)
7.4.2 Global Therapeutic Nuclear Medicines Consumption Value and Growth Rate of Bone Metastasis(2022-2027)
7.4.3 Global Therapeutic Nuclear Medicines Consumption Value and Growth Rate of Lymphoma(2022-2027)
7.4.4 Global Therapeutic Nuclear Medicines Consumption Value and Growth Rate of Other(2022-2027)
7.5 Therapeutic Nuclear Medicines Market Forecast Under COVID-19
8 THERAPEUTIC NUCLEAR MEDICINES MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Therapeutic Nuclear Medicines Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Therapeutic Nuclear Medicines Analysis
8.6 Major Downstream Buyers of Therapeutic Nuclear Medicines Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Therapeutic Nuclear Medicines Industry
9 PLAYERS PROFILES
9.1 Acrotech Biopharma.
9.1.1 Acrotech Biopharma. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.1.3 Acrotech Biopharma. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Progenics Pharmaceuticals
9.2.1 Progenics Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.2.3 Progenics Pharmaceuticals Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Curium Pharmaceuticals
9.3.1 Curium Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.3.3 Curium Pharmaceuticals Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Q BioMed
9.4.1 Q BioMed Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.4.3 Q BioMed Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Lantheus
9.5.1 Lantheus Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.5.3 Lantheus Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Jubilant DraxImage
9.6.1 Jubilant DraxImage Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.6.3 Jubilant DraxImage Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 International Isotopes
9.7.1 International Isotopes Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.7.3 International Isotopes Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Dongcheng
9.8.1 Dongcheng Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.8.3 Dongcheng Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Novartis AG
9.9.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.9.3 Novartis AG Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 China Isotope and Radiation
9.10.1 China Isotope and Radiation Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.10.3 China Isotope and Radiation Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Bayer
9.11.1 Bayer Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.11.3 Bayer Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines Market
1.2 Therapeutic Nuclear Medicines Market Segment by Type
1.2.1 Global Therapeutic Nuclear Medicines Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Therapeutic Nuclear Medicines Market Segment by Application
1.3.1 Therapeutic Nuclear Medicines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Therapeutic Nuclear Medicines Market, Region Wise (2017-2027)
1.4.1 Global Therapeutic Nuclear Medicines Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.3 Europe Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.4 China Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.5 Japan Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.6 India Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.8 Latin America Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Therapeutic Nuclear Medicines Market Status and Prospect (2017-2027)
1.5 Global Market Size of Therapeutic Nuclear Medicines (2017-2027)
1.5.1 Global Therapeutic Nuclear Medicines Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Therapeutic Nuclear Medicines Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Therapeutic Nuclear Medicines Market
2 INDUSTRY OUTLOOK
2.1 Therapeutic Nuclear Medicines Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Therapeutic Nuclear Medicines Market Drivers Analysis
2.4 Therapeutic Nuclear Medicines Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Therapeutic Nuclear Medicines Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Therapeutic Nuclear Medicines Industry Development
3 GLOBAL THERAPEUTIC NUCLEAR MEDICINES MARKET LANDSCAPE BY PLAYER
3.1 Global Therapeutic Nuclear Medicines Sales Volume and Share by Player (2017-2022)
3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Player (2017-2022)
3.3 Global Therapeutic Nuclear Medicines Average Price by Player (2017-2022)
3.4 Global Therapeutic Nuclear Medicines Gross Margin by Player (2017-2022)
3.5 Therapeutic Nuclear Medicines Market Competitive Situation and Trends
3.5.1 Therapeutic Nuclear Medicines Market Concentration Rate
3.5.2 Therapeutic Nuclear Medicines Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL THERAPEUTIC NUCLEAR MEDICINES SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Therapeutic Nuclear Medicines Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Therapeutic Nuclear Medicines Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Therapeutic Nuclear Medicines Market Under COVID-19
4.5 Europe Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Therapeutic Nuclear Medicines Market Under COVID-19
4.6 China Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Therapeutic Nuclear Medicines Market Under COVID-19
4.7 Japan Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Therapeutic Nuclear Medicines Market Under COVID-19
4.8 India Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Therapeutic Nuclear Medicines Market Under COVID-19
4.9 Southeast Asia Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Therapeutic Nuclear Medicines Market Under COVID-19
4.10 Latin America Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Therapeutic Nuclear Medicines Market Under COVID-19
4.11 Middle East and Africa Therapeutic Nuclear Medicines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Therapeutic Nuclear Medicines Market Under COVID-19
5 GLOBAL THERAPEUTIC NUCLEAR MEDICINES SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Therapeutic Nuclear Medicines Sales Volume and Market Share by Type (2017-2022)
5.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2017-2022)
5.3 Global Therapeutic Nuclear Medicines Price by Type (2017-2022)
5.4 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate of Radium-223 (2017-2022)
5.4.2 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate of Lutetium-177 (2017-2022)
5.4.3 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate of Iodine-131 (2017-2022)
5.4.4 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate of Other (2017-2022)
6 GLOBAL THERAPEUTIC NUCLEAR MEDICINES MARKET ANALYSIS BY APPLICATION
6.1 Global Therapeutic Nuclear Medicines Consumption and Market Share by Application (2017-2022)
6.2 Global Therapeutic Nuclear Medicines Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Therapeutic Nuclear Medicines Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Thyroid (2017-2022)
6.3.2 Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Bone Metastasis (2017-2022)
6.3.3 Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Lymphoma (2017-2022)
6.3.4 Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Other (2017-2022)
7 GLOBAL THERAPEUTIC NUCLEAR MEDICINES MARKET FORECAST (2022-2027)
7.1 Global Therapeutic Nuclear Medicines Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Therapeutic Nuclear Medicines Price and Trend Forecast (2022-2027)
7.2 Global Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Therapeutic Nuclear Medicines Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Therapeutic Nuclear Medicines Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Therapeutic Nuclear Medicines Revenue and Growth Rate of Radium-223 (2022-2027)
7.3.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate of Lutetium-177 (2022-2027)
7.3.3 Global Therapeutic Nuclear Medicines Revenue and Growth Rate of Iodine-131 (2022-2027)
7.3.4 Global Therapeutic Nuclear Medicines Revenue and Growth Rate of Other (2022-2027)
7.4 Global Therapeutic Nuclear Medicines Consumption Forecast by Application (2022-2027)
7.4.1 Global Therapeutic Nuclear Medicines Consumption Value and Growth Rate of Thyroid(2022-2027)
7.4.2 Global Therapeutic Nuclear Medicines Consumption Value and Growth Rate of Bone Metastasis(2022-2027)
7.4.3 Global Therapeutic Nuclear Medicines Consumption Value and Growth Rate of Lymphoma(2022-2027)
7.4.4 Global Therapeutic Nuclear Medicines Consumption Value and Growth Rate of Other(2022-2027)
7.5 Therapeutic Nuclear Medicines Market Forecast Under COVID-19
8 THERAPEUTIC NUCLEAR MEDICINES MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Therapeutic Nuclear Medicines Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Therapeutic Nuclear Medicines Analysis
8.6 Major Downstream Buyers of Therapeutic Nuclear Medicines Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Therapeutic Nuclear Medicines Industry
9 PLAYERS PROFILES
9.1 Acrotech Biopharma.
9.1.1 Acrotech Biopharma. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.1.3 Acrotech Biopharma. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Progenics Pharmaceuticals
9.2.1 Progenics Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.2.3 Progenics Pharmaceuticals Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Curium Pharmaceuticals
9.3.1 Curium Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.3.3 Curium Pharmaceuticals Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Q BioMed
9.4.1 Q BioMed Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.4.3 Q BioMed Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Lantheus
9.5.1 Lantheus Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.5.3 Lantheus Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Jubilant DraxImage
9.6.1 Jubilant DraxImage Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.6.3 Jubilant DraxImage Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 International Isotopes
9.7.1 International Isotopes Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.7.3 International Isotopes Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Dongcheng
9.8.1 Dongcheng Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.8.3 Dongcheng Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Novartis AG
9.9.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.9.3 Novartis AG Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 China Isotope and Radiation
9.10.1 China Isotope and Radiation Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.10.3 China Isotope and Radiation Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Bayer
9.11.1 Bayer Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
9.11.3 Bayer Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Therapeutic Nuclear Medicines Product Picture
Table Global Therapeutic Nuclear Medicines Market Sales Volume and CAGR (%) Comparison by Type
Table Therapeutic Nuclear Medicines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Therapeutic Nuclear Medicines Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Therapeutic Nuclear Medicines Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Therapeutic Nuclear Medicines Industry Development
Table Global Therapeutic Nuclear Medicines Sales Volume by Player (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Volume Share by Player (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume Share by Player in 2021
Table Therapeutic Nuclear Medicines Revenue (Million USD) by Player (2017-2022)
Table Therapeutic Nuclear Medicines Revenue Market Share by Player (2017-2022)
Table Therapeutic Nuclear Medicines Price by Player (2017-2022)
Table Therapeutic Nuclear Medicines Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Therapeutic Nuclear Medicines Sales Volume, Region Wise (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share, Region Wise in 2021
Table Global Therapeutic Nuclear Medicines Revenue (Million USD), Region Wise (2017-2022)
Table Global Therapeutic Nuclear Medicines Revenue Market Share, Region Wise (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share, Region Wise (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share, Region Wise in 2021
Table Global Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Volume by Type (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2021
Table Global Therapeutic Nuclear Medicines Revenue (Million USD) by Type (2017-2022)
Table Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type in 2021
Table Therapeutic Nuclear Medicines Price by Type (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate of Radium-223 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Radium-223 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate of Lutetium-177 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Lutetium-177 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate of Iodine-131 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Iodine-131 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate of Other (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Other (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption by Application (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption Revenue Market Share by Application (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Thyroid (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Bone Metastasis (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Lymphoma (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Other (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Therapeutic Nuclear Medicines Price and Trend Forecast (2022-2027)
Figure USA Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Therapeutic Nuclear Medicines Market Sales Volume Forecast, by Type
Table Global Therapeutic Nuclear Medicines Sales Volume Market Share Forecast, by Type
Table Global Therapeutic Nuclear Medicines Market Revenue (Million USD) Forecast, by Type
Table Global Therapeutic Nuclear Medicines Revenue Market Share Forecast, by Type
Table Global Therapeutic Nuclear Medicines Price Forecast, by Type
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Radium-223 (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Radium-223 (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Lutetium-177 (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Lutetium-177 (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Iodine-131 (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Iodine-131 (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Other (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Other (2022-2027)
Table Global Therapeutic Nuclear Medicines Market Consumption Forecast, by Application
Table Global Therapeutic Nuclear Medicines Consumption Market Share Forecast, by Application
Table Global Therapeutic Nuclear Medicines Market Revenue (Million USD) Forecast, by Application
Table Global Therapeutic Nuclear Medicines Revenue Market Share Forecast, by Application
Figure Global Therapeutic Nuclear Medicines Consumption Value (Million USD) and Growth Rate of Thyroid (2022-2027)
Figure Global Therapeutic Nuclear Medicines Consumption Value (Million USD) and Growth Rate of Bone Metastasis (2022-2027)
Figure Global Therapeutic Nuclear Medicines Consumption Value (Million USD) and Growth Rate of Lymphoma (2022-2027)
Figure Global Therapeutic Nuclear Medicines Consumption Value (Million USD) and Growth Rate of Other (2022-2027)
Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Acrotech Biopharma. Profile
Table Acrotech Biopharma. Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Acrotech Biopharma. Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Acrotech Biopharma. Revenue (Million USD) Market Share 2017-2022
Table Progenics Pharmaceuticals Profile
Table Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Progenics Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Curium Pharmaceuticals Profile
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Curium Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Q BioMed Profile
Table Q BioMed Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Q BioMed Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Q BioMed Revenue (Million USD) Market Share 2017-2022
Table Lantheus Profile
Table Lantheus Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lantheus Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Lantheus Revenue (Million USD) Market Share 2017-2022
Table Jubilant DraxImage Profile
Table Jubilant DraxImage Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Jubilant DraxImage Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Jubilant DraxImage Revenue (Million USD) Market Share 2017-2022
Table International Isotopes Profile
Table International Isotopes Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure International Isotopes Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure International Isotopes Revenue (Million USD) Market Share 2017-2022
Table Dongcheng Profile
Table Dongcheng Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dongcheng Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Dongcheng Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table China Isotope and Radiation Profile
Table China Isotope and Radiation Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure China Isotope and Radiation Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure China Isotope and Radiation Revenue (Million USD) Market Share 2017-2022
Table Bayer Profile
Table Bayer Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Bayer Revenue (Million USD) Market Share 2017-2022
Figure Therapeutic Nuclear Medicines Product Picture
Table Global Therapeutic Nuclear Medicines Market Sales Volume and CAGR (%) Comparison by Type
Table Therapeutic Nuclear Medicines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Therapeutic Nuclear Medicines Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Therapeutic Nuclear Medicines Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Therapeutic Nuclear Medicines Industry Development
Table Global Therapeutic Nuclear Medicines Sales Volume by Player (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Volume Share by Player (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume Share by Player in 2021
Table Therapeutic Nuclear Medicines Revenue (Million USD) by Player (2017-2022)
Table Therapeutic Nuclear Medicines Revenue Market Share by Player (2017-2022)
Table Therapeutic Nuclear Medicines Price by Player (2017-2022)
Table Therapeutic Nuclear Medicines Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Therapeutic Nuclear Medicines Sales Volume, Region Wise (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share, Region Wise in 2021
Table Global Therapeutic Nuclear Medicines Revenue (Million USD), Region Wise (2017-2022)
Table Global Therapeutic Nuclear Medicines Revenue Market Share, Region Wise (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share, Region Wise (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share, Region Wise in 2021
Table Global Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Volume by Type (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2021
Table Global Therapeutic Nuclear Medicines Revenue (Million USD) by Type (2017-2022)
Table Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type in 2021
Table Therapeutic Nuclear Medicines Price by Type (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate of Radium-223 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Radium-223 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate of Lutetium-177 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Lutetium-177 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate of Iodine-131 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Iodine-131 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate of Other (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Other (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption by Application (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption Revenue Market Share by Application (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Thyroid (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Bone Metastasis (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Lymphoma (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption and Growth Rate of Other (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Therapeutic Nuclear Medicines Price and Trend Forecast (2022-2027)
Figure USA Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Therapeutic Nuclear Medicines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Therapeutic Nuclear Medicines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Therapeutic Nuclear Medicines Market Sales Volume Forecast, by Type
Table Global Therapeutic Nuclear Medicines Sales Volume Market Share Forecast, by Type
Table Global Therapeutic Nuclear Medicines Market Revenue (Million USD) Forecast, by Type
Table Global Therapeutic Nuclear Medicines Revenue Market Share Forecast, by Type
Table Global Therapeutic Nuclear Medicines Price Forecast, by Type
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Radium-223 (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Radium-223 (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Lutetium-177 (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Lutetium-177 (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Iodine-131 (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Iodine-131 (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Other (2022-2027)
Figure Global Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate of Other (2022-2027)
Table Global Therapeutic Nuclear Medicines Market Consumption Forecast, by Application
Table Global Therapeutic Nuclear Medicines Consumption Market Share Forecast, by Application
Table Global Therapeutic Nuclear Medicines Market Revenue (Million USD) Forecast, by Application
Table Global Therapeutic Nuclear Medicines Revenue Market Share Forecast, by Application
Figure Global Therapeutic Nuclear Medicines Consumption Value (Million USD) and Growth Rate of Thyroid (2022-2027)
Figure Global Therapeutic Nuclear Medicines Consumption Value (Million USD) and Growth Rate of Bone Metastasis (2022-2027)
Figure Global Therapeutic Nuclear Medicines Consumption Value (Million USD) and Growth Rate of Lymphoma (2022-2027)
Figure Global Therapeutic Nuclear Medicines Consumption Value (Million USD) and Growth Rate of Other (2022-2027)
Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Acrotech Biopharma. Profile
Table Acrotech Biopharma. Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Acrotech Biopharma. Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Acrotech Biopharma. Revenue (Million USD) Market Share 2017-2022
Table Progenics Pharmaceuticals Profile
Table Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Progenics Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Curium Pharmaceuticals Profile
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Curium Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Q BioMed Profile
Table Q BioMed Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Q BioMed Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Q BioMed Revenue (Million USD) Market Share 2017-2022
Table Lantheus Profile
Table Lantheus Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lantheus Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Lantheus Revenue (Million USD) Market Share 2017-2022
Table Jubilant DraxImage Profile
Table Jubilant DraxImage Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Jubilant DraxImage Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Jubilant DraxImage Revenue (Million USD) Market Share 2017-2022
Table International Isotopes Profile
Table International Isotopes Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure International Isotopes Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure International Isotopes Revenue (Million USD) Market Share 2017-2022
Table Dongcheng Profile
Table Dongcheng Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dongcheng Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Dongcheng Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table China Isotope and Radiation Profile
Table China Isotope and Radiation Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure China Isotope and Radiation Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure China Isotope and Radiation Revenue (Million USD) Market Share 2017-2022
Table Bayer Profile
Table Bayer Therapeutic Nuclear Medicines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer Therapeutic Nuclear Medicines Sales Volume and Growth Rate
Figure Bayer Revenue (Million USD) Market Share 2017-2022
